MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on October 20, 2004; DOI: 10.1124/mol.104.004465


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.004465v1
67/1/105    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stirone, C.
Right arrow Articles by Krause, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stirone, C.
Right arrow Articles by Krause, D.


Received for publication July 9, 2004.
Revised October 12, 2004.
Accepted for publication October 19, 2004.

Estrogen receptor activation of PI-3 kinase, Akt and nitric oxide signaling in cerebral blood vessels: rapid and chronic effects

Chris Stirone 1, Amin Boroujerdi 2, Sue Duckles 2, Diana Krause 2*

1 Univeristy of California, Irvine 2 University of California, Irvine

* Address correspondence to: E-mail: dnkrause{at}uci.edu

Abstract

Estrogen receptor regulation of nitric oxide (NO) production by vascular endothelium may involve rapid, membrane-initiated signaling pathways in addition to classic genomic mechanisms. Here we demonstrate using intact cerebral blood vessels that 17{beta}-estradiol acutely activates endothelial NO synthase (eNOS) via the phosphoinositide-3 (PI-3) kinase-Akt kinase pathway. The effect is mediated by estrogen receptors (ER), consistent with co-localization of ER{alpha} and caveolin-1 immunoreactivity at the plasma membrane of endothelial cells lining cerebral arteries. Treatment with 17{beta}-estradiol (10 nM) for 30 min increased NO production, as measured by total nitrite assay, in cerebral vessels isolated from ovariectomized rats. This effect was significantly decreased by membrane cholesterol depletion with {beta}-methyl-cyclodextrin, the ER antagonist ICI 182,780, and two inhibitors of PI-3 kinase: wortmannin and LY294002. In parallel with NO production, acute 17{beta}-estradiol treatment increased phosphorylation of both eNOS (p-eNOS) and Akt (p-Akt). PI-3 kinase inhibitors also blocked these effects. ER{alpha} protein (66 and 50 kDa) co-immunoprecipitated with eNOS as well as with the p85{alpha} regulatory subunit of PI-3 kinase, further implicating ER{alpha} in kinase activation of eNOS. Little is known regarding effects of estrogen on cellular kinase pathways in vivo; therefore we compared cerebral blood vessels isolated from ovariectomized rats that were either untreated or given estrogen replacement for 4 weeks. Chronic estrogen exposure increased levels of cerebrovascular p-Akt and p-eNOS, as well as basal NO production. Thus, in addition to rapid activation of the PI3 kinase-pAkt-peNOS pathway, maintenance of estrogen signaling via non-transcriptional mechanisms has long-term consequences for vascular function.


Key words: Nitric oxide, Nitric oxide synthases, Sex hormones, Protein Kinases (other)





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics